Australia Cannabis News Wrap-Up 2022 – The Year Cannabis Went Properly Mainstream

2022 Australian Cannabis Industry Wrap-up

If 2020 & 2021 was the subtle knock on the medicinal Cannabis knock on the door, then 2022 was the medicinal cannabis officially kicked down the front door!

Patients exploded into the hundreds of thousands. Prescriptions surged. Cannabis clinics multiplied faster than kebab shops after midnight. Politicians started talking more seriously about driving law reform. Regulators scrambled to keep up with an industry growing at warp speed. Even mainstream media stopped treating medicinal cannabis stories like they were covering a cartel raid in Colombia.

At the same time, Australia remained deeply confused about cannabis generally. Medicinal cannabis was becoming more accepted by the month, yet recreational cannabis remained largely illegal federally, roadside testing laws stayed outdated, and patients were still being punished for legally prescribed medication.

In other words, classic Australia. Half progressive healthcare reform, half “nah mate that’s still illegal.” Still, 2022 was undeniably one of the biggest years in Australian cannabis history.

Here’s the full wrap-up of the major stories, trends, controversies and developments that shaped cannabis in Australia throughout 2022.

Medicinal Cannabis Patient Numbers Exploded

The biggest story of 2022 was simple: medicinal cannabis went properly mainstream. Patient access accelerated dramatically throughout the year, driven largely by telehealth services, increased doctor confidence and broader public acceptance.

By the end of 2022, medicinal cannabis prescriptions in Australia had risen massively compared to previous years, with industry analysts describing growth as “explosive.” Australians were spending hundreds of millions of dollars annually on medicinal cannabis products by this stage.

External article:
https://www.theguardian.com/australia-news/2024/nov/28/australias-booming-medicinal-cannabis-trade-on-track-this-year-to-quadruple-2022-sales

The major shift wasn’t just numbers. It was demographics. Early medicinal cannabis access in Australia had largely centred around severe illnesses and highly publicised compassionate access cases. By 2022, however, prescriptions were increasingly being written for:

Chronic pain
Anxiety
Sleep disorders
PTSD
Inflammation
Neurological conditions

Suddenly medicinal cannabis wasn’t just something discussed in activist circles or alternative health forums. Everyday Australians were openly talking about prescriptions at barbecues, workplaces and family dinners.

Even older Australians who once viewed cannabis as “that thing naughty teenagers smoked behind the train station” started becoming medicinal cannabis patients themselves.

Funny how quickly opinions can evolve when arthritis turns up.

Cannabis Clinics Became Big Business

One of the most noticeable developments during 2022 was the rapid rise of dedicated medicinal cannabis clinics. Telehealth-based prescribing services exploded in popularity across Australia, dramatically increasing access for patients in regional areas and reducing barriers around specialist appointments.

Patients who previously struggled navigating traditional healthcare pathways could suddenly access consultations online from home. This created enormous growth opportunities for both clinics and product suppliers.

But the rapid expansion also triggered criticism.

Questions started emerging around:

Overprescribing
Commercial conflicts
“Tick-and-flick” consultations
Aggressive marketing
Product quality consistency

Regulators and medical bodies increasingly began scrutinising whether some operators were prioritising growth over patient care. That debate would only intensify in later years, but 2022 was when the conversation really started gaining momentum.

Driving Laws Became One Of Australia’s Biggest Cannabis Debates

Another major issue dominating cannabis discussions throughout 2022 was roadside drug testing laws.

Medicinal cannabis patients across Australia continued facing the bizarre situation where they could legally obtain prescribed THC products but still lose their licence for simply having THC present in their saliva while driving.

Importantly, roadside tests detect presence, not impairment.

That means patients could test positive many hours or even days after consumption despite not being impaired whatsoever.

Several politicians, advocacy groups and legal experts began pushing more seriously for reform during 2022.

Queensland Greens MP Michael Berkman notably proposed amendments seeking protections for medicinal cannabis patients who were not impaired while driving.

External document:
https://www.parliament.qld.gov.au/docs/find.aspx?id=5722T1248

Victoria also continued reviewing cannabis-related road safety laws following recommendations from parliamentary inquiries which acknowledged current THC testing methods do not adequately measure impairment.

External article:
https://en.wikipedia.org/wiki/Cannabis_in_Australia

By the end of 2022, the issue had become one of the single biggest barriers preventing some Australians from accessing medicinal cannabis treatment.

For many patients, losing the ability to drive meant losing employment, independence or both. Meanwhile someone prescribed heavy opioids could legally drive provided they were not impaired.

Naturally, patients found this slightly ridiculous.

Cannabis Reform Discussions Became More Serious

While recreational cannabis remained illegal federally throughout 2022, public attitudes toward broader cannabis reform continued shifting significantly.

Support for legalisation steadily increased nationally, particularly among younger Australians but increasingly across older demographics as well.

Media coverage also became noticeably more balanced compared to previous decades.

Earlier cannabis discussions in Australia often swung between two extremes:

“Cannabis cures everything.”
“Cannabis destroys civilisation.”

By 2022, conversations had become more grounded and practical.

The focus increasingly shifted toward:

Harm minimisation
Regulation
Patient rights
Public health
Taxation models
Criminal justice reform

Cannabis legalisation was no longer viewed as some fringe radical proposal. It had become a mainstream political discussion.

Not everyone agreed on the details, of course. But the tone had changed dramatically.

The ACT Continued Its Strange Cannabis Experiment

The Australian Capital Territory remained Australia’s weird little cannabis experiment throughout 2022.

Personal possession and small-scale home cultivation technically remained legal within the ACT under territory law, despite ongoing conflicts with federal legislation.

This created ongoing confusion around:

Supply legality
Seed acquisition
Federal jurisdiction
Enforcement boundaries

Still, the ACT effectively became Australia’s closest thing to partial cannabis legalisation.

Predictably, the apocalypse failed to occur.

Canberra largely continued functioning exactly as before, except now politicians could theoretically complain about cannabis laws while legally growing two plants in their backyard.

Australian Cannabis Cultivation Expanded Rapidly

2022 also saw significant growth across Australia’s legal cultivation sector.

Licensed medicinal cannabis production facilities expanded nationally as companies attempted to position themselves within the rapidly growing domestic market.

Industry discussions increasingly focused on:

Australian-grown flower quality
Indoor vs greenhouse production
Export potential
Genetics
Cost efficiency
GMP compliance

Australia’s climate and agricultural expertise positioned the country as a potentially significant global cannabis producer long term, although heavy regulation remained a major hurdle for smaller operators.

External article:
https://www.odc.gov.au/about-us/reviews-and-reforms/medicinal-cannabis-single-licence-and-permit-reforms

At the community level, Australian growers also became noticeably more sophisticated.

Online discussions increasingly focused on:

Environmental optimisation
Living soil systems
LED technology
Drying and curing science
Terpene preservation
Genetics stability
Autoflower performance

The days of random nutrient schedules copied from a blurry forum post in 2009 were slowly fading away.

Well… mostly.

Autoflower Genetics Became Hugely Popular In Australia

Autoflower cannabis strains saw massive growth in popularity during 2022, particularly among newer Australian growers.

Several factors drove the trend:

Faster harvest cycles
Simpler growing process
Better resilience
Compact growth habits
Improved modern genetics

Australian growers dealing with harsh summers, humidity and shorter outdoor seasons increasingly gravitated toward quicker-finishing genetics.

Modern autoflowers also improved dramatically compared to early-generation autos from years prior.

Internal guide:
https://www.cgaustralia.com.au/product-category/cannabis-seeds/auto/

Photoperiod genetics still dominated among experienced growers chasing maximum yields and cloning consistency, but autoflowers firmly established themselves as a serious category by 2022.

Internal guide:
https://www.cgaustralia.com.au/product-category/cannabis-seeds/photo-period

Grow Guides And Cannabis Education Became More Important

As Australia’s cannabis community expanded, educational content became increasingly important.

Growers wanted practical information rather than recycled myths or outdated advice.

Searches surged around:

Germination
Seedling care
Nutrient schedules
Flowering stages
Drying and curing
Deficiencies
Environmental control

Cannabis education content exploded across Australian websites, YouTube channels and forums.

The broader cannabis community became noticeably more knowledge-driven overall.

Internal grow guide:
https://www.cgaustralia.com.au/cannabis-growing-guide-australia/

Media Stigma Around Cannabis Continued Declining

One of the quieter but most important changes throughout 2022 was the continued decline in cannabis stigma within mainstream Australian media.

Media coverage became noticeably more nuanced and less sensationalist.

Stories increasingly featured:

Medical professionals
Patients
Industry experts
Economic analysis
Policy discussions

Instead of treating cannabis solely as a criminal issue, mainstream outlets increasingly covered it as:

A healthcare issue
A regulatory issue
An economic issue
A social policy issue

That change in tone matters more than many people realise.

Public opinion often follows media normalisation long before legislation catches up.

Cannabis Activism Stayed Loud And Creative

Australia’s cannabis activist community also remained highly visible during 2022.

Groups including “Who Are We Hurting?” continued using public demonstrations, projections and media stunts to push for reform and challenge outdated cannabis policies.

One widely discussed stunt involved projecting cannabis imagery onto iconic Sydney landmarks during 4/20 activism campaigns.

External article:
https://en.wikipedia.org/wiki/Cannabis_in_Australia

While opinions on activist tactics varied, the broader impact was obvious:
Cannabis reform discussions were no longer staying hidden in niche communities.

They had entered mainstream political and public conversation permanently.

Closing Summary

By the end of 2022, one thing had become very clear.

Australia’s cannabis industry was no longer some fringe side conversation happening quietly in the background.

Medicinal cannabis had become a serious national healthcare and economic sector.

Patients were increasing rapidly.
Doctors were prescribing more confidently.
Businesses were scaling aggressively.
Public opinion was shifting steadily.
Politicians were under increasing pressure to modernise laws.

At the same time, Australia remained caught in an awkward transition period where old laws increasingly conflicted with new realities.

That tension would continue building in the years ahead.

Still, 2022 marked a genuine turning point.

Cannabis stopped being something Australians whispered about and started becoming something openly discussed in parliament, media, healthcare and everyday life.

And honestly, after decades of hysterical nonsense surrounding the plant, that alone was probably overdue.

Further Reading:
https://www.cannabiz.com.au/
https://www.abc.net.au/news/topic/cannabis
https://cannabiscouncil.org.au/news-and-updates
https://www.odc.gov.au/medicinal-cannabis

About the author:

As a passionate grower of all plants, CG advocates for moderation and reverence of Cannabis as an ancient and powerful natural medicine. As the taboo is finally lifting worldwide, rational free thinking adults can experience the joy and wonder of growing a marijuana plant and we’re so thank-full to our members and the growing community for sharing responsibly. Thank-you everyone.